Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
NewYou can now listen to Fox News articles!
The new study has been discovered by another way to potentially Prevent CVIVI-19.
Researchers at the Saarland University in Germany set out a clinical examination found by a nasal spray could reduce the risk of a coronary infection of two thirds.
The Phase 2 studyPublished in State Internal Medicine, it is in March 2023. until July 2024. in the Saarland University Hospital.
The new cover variant can cause the “Gritovice throat” – here is what to know
450 healthy adult participants randomly assigned to receive any azelastin nasal spray or placebo, three times a day for 56 days.
The researchers conducted SARS-COV-2 quickly testing antigens twice a week to diagnose infection. People who had symptoms, but received negative results of antigen testing that passed multiple PCR tests for Respiratory viruses.
Azelastin Nasal spray can potentially delay CVIVI-19 infection, according to new research. (East)
Among 227 individuals who received a spray of azelastina nasal spray, the rates of confirmed applications were “significantly lower” to 2.2%, compared to 6.7% for the placebo group.
Click here to sign up for our health Newsletter
Researchers also noticed an increase in the period before the infection towards people taking azelastine. In these patients, the drug was associated with a lower symptomatic infection rate confirmed by PCR and fewer confirmed ronoader infections (primary cause cold).
Azelastin nasal spray can also help prevent other respiratory viruses, researchers found. (East)
“In this trial one center, Azelastin nasal spray It was associated with reduced risk of SARS-2 respiratory infections, “researchers wrote.
Azelastine is available as a purification of excessive fever, according to the public announcement from the Saarland University, and was previously suggested to have an antivirus effect on advisory Respiratory viruses.
Click here to get Fox News app
Lead judged researcher Professor Robert Bals, director of the Saarland’s Medical Center, commented on the statement that the trial showed that the trial showed the impact of Azelastin in “Real World”. “
Azelastin led to a reduction in the number of symptomatic infections confirmed by PCR, in accordance with the study. (East)
“Azelastine Nasal spray could provide an additional, easily accessible prophylactic to supplement existing protective measures, especially for vulnerable groups, during the high period period Infection rates or before the trip, “he continued.
For more healthcare articles, visit www.foknevs.com/iealth
“Our results emphasize the need for higher, multiplayer trials to explore the use of azelastic nasal sprays as preventive treatment on request and examine its potential efficiency towards other respiratory pathogens.”
Fox News Digital reached the commentary researchers.
